ClinicalTrials.gg
Not yet recruitingNCT06909552Updated Jul 25, 2025

Use of an Educational Video to Improve Adherence to Treatment in Voiding Dysfunction

An interventional study of Educational Video on Voiding Dysfunction in Dysfunctional Voiding, sponsored by University of Colorado, Denver. Not yet recruiting at 1 site in United States. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-07-25.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Supportive care

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
5 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 75 studies in Treatment Adherence and Compliance with a site in United States — 12 open to participants now, 15 under way, none of them phase 3. Treatment Adherence and Compliance · United States.

Planned enrollment
26th of 70
100 · median 66
Started
2025
with 1 other
No phase
58 of 75
8 open now
Primary completion
2027-07
later than 6 of 14 live
Registered
68th of 75
by date

Among the 75 studies in Treatment Adherence and Compliance with a site in United States, this one is the 26th largest by planned enrollment of the 70 interventional ones that give a count, is one of 2 that started in 2025, is one of 58 with no phase, reaches primary completion later than 6 of the 14 other live ones, and was the 68th registered.

Treatment Adherence and Compliance

353 studies on the registry are indexed under Treatment Adherence and Compliance; 108 are open to participants now.

Browse Treatment Adherence and Compliance studies →

Open to participants now

12 of the 75 studies in Treatment Adherence and Compliance with a site in United States are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 59 Treatment Adherence and Compliance studies recruiting now, 46 (78%) set no upper age limit and 12 (20%) stop at 75 or younger; 7 take children under 18; 7 take healthy volunteers.

This study: 5 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 75 studies in Treatment Adherence and Compliance with a site in United States, or all of them as a file.
02

Study summary

This study aims to see whether an educational video on a common urinary dysfunction leads to improved parent and child perceived adherence to treatments recommendations.

Read the detailed description

This study aims to explore whether the use of an educational video on voiding dysfunction, a common urinary dysfunction, leads to improve parents and child perceived adherence to behavioral treatment recommendations. Our main hypothesis explores whether there is improved perceived adherence, and whether this improved perceived adherence leads to better symptom outcomes in this condition.

We do so through randomizing patients to a control and intervention group, where the latter is exposed to the educational video, while the control group experiences standard of care visits/follow-ups. Data is collected through surveys pre and post exposure to the intervention.

03

Conditions studied

  • Dysfunctional Voiding

Keywords

  • dysfunctional voiding
  • educational video
  • treatment adherence
  • behavioral modification
04

Who can participate

Ages eligible
5 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Parents and Caregivers of pediatric urology patients with a diagnosis of Dysfunctional voiding (minimum 100 participants)
  • 5-18 years old, no younger than 5 and no older than 18 years old
  • Potty-trained - fully independent with toileting, can complete every step of the process and can do so satisfactorily by themselves.

Exclusion criteria

Exclusion Criteria:

  • Children with Voiding dysfunctionDysfunctional voiders with medically complex conditions (neurogenic bladder, POTS, EDS, etc.)
  • Parent's child is notNot a first-time patient (i.e. has been seen in the past for dysfunctional voiding)
  • Child has severeSevere intellectual disability, developmental delay, or cognitive impairment.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Educational Video

    Participants will be exposed to a short 3-minute educational video following a visit with their urology provider.

    Other: Educational Video on Voiding Dysfunction

  • No intervention
    Control

    Participants will not be exposed to an educational video; rather, they will receive standard of care education in clinic regarding behavioral treatment modalities at home.

Interventions

  • OtherEducational Video on Voiding Dysfunction

    The educational video is a short 3-minute video which describes the condition in detail, at the level that a parent or child could understand without a medical background.

06

What researchers measure

Primary outcomes

  1. Perceived Adherence

    Participants will take the TAPQ perceived adherence assessment at time points 4 weeks and 8 weeks.

    Time frame: 4 weeks, 8 weeks.

Secondary outcomes

  1. Video Acceptability

    Immediately after watching the educational video, participants will be asked to complete a questionnaire on the acceptability of the video. this will occur at time frame 0 weeks (for intervention group).

    Time frame: 0 weeks.

  2. Dysfunctional Voiding Scoring System

    Participants will be asked to complete a DVSS survey at timepoints 0 weeks, 4 weeks, and 8 weeks. This DVSS survey will be used to assess symptom improvement throughout the study.

    Time frame: 0 weeks, 4 weeks, and 8 weeks.

07

Study locations

1 site
08

References and documents

Publications

  • Feldman AS, Bauer SB. Diagnosis and management of dysfunctional voiding. Curr Opin Pediatr. 2006 Apr;18(2):139-47. doi: 10.1097/01.mop.0000193289.64151.49. PubMed 16601493 ↗
  • Dyson PA, Beatty S, Matthews DR. An assessment of lifestyle video education for people newly diagnosed with type 2 diabetes. J Hum Nutr Diet. 2010 Aug;23(4):353-9. doi: 10.1111/j.1365-277X.2010.01077.x. Epub 2010 May 20. PubMed 20497292 ↗

Individual participant data

Plan to share: No — resource limitations

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2025; primary completion for Jul 2027, 23 months later.

Of 180 non-industry interventional studies with no phase under Treatment Adherence and Compliance, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 36. This study's planned 23 months is above that.

Counting every sponsor, half of 185 studies reached it within 17 months; a quarter within 9 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 27, 2025
First posted
Apr 3, 2025
StartEst.
Aug 1, 2025
Primary completionEst.
Jul 31, 2027
CompletionEst.
Jul 31, 2027
Last update
Jul 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06909552
Responsible party
Sponsor
First posted
Apr 3, 2025
Start date
Aug 1, 2025 (estimated)
Primary completion
Jul 31, 2027 (estimated)
Completion
Jul 31, 2027 (estimated)
Last update
Jul 25, 2025

Study contacts

Marguerite Korber, CPNP
Contact
marguerite.korber@childrenscolorado.org
720-777-6523

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion